Search results
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology via Yahoo Finance· 3 days agoZai Lab has announced that its New Drug Application (NDA) for Augtyro (repotrectinib) has been...
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
FierceBiotech· 3 days agoCytokinetics has set out to prove that aficamten is a threat to Bristol Myers Squibb’s $13.1 billion...
FDA Broadens Breyanzi's Follicular Lymphoma Indication
Medscape· 9 hours agoThe overall response rate to the CAR T therapy was 95.7% in phase 2 testing.
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 6 days agoCatalyst Pharmaceuticals' new Chief Executive, Richard Daly, is no stranger to working at big...
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Zacks via Yahoo Finance· 7 days agoProthena Corporation PRTA reported a loss of $1.34 per share in first-quarter 2024, wider than the...
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoEditas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript May 8, 2024 Editas Medicine,...
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 3 days agoFor Immediate Release Chicago, IL – May 13, 2024 – Zacks Equity Research shares Veeva Systems VEEV...
Inflation and consumer spending updates ahead: What to know this week
Yahoo Finance· 3 days agoA crucial reading of inflation faces investors in the week ahead after a string of disappointing...
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields -...
Benzinga· 6 days agoLoading... Loading... During times of turbulence and uncertainty in the markets, many investors turn...
This company has been the biggest drag on the S&P 500’s results this quarter
Market Watch· 4 days agoHigher prices for groceries, which make up a majority of Walmart’s sales, have helped, even as...